ADVANCES AND CHALLENGES IN CONTINUOUS GLUCOSE MONITORING FOR DIABETES MANAGEMENT. A NARRATIVE REVIEW

Joanna Ciemięga; Jakub Klecha; Emilia  Kucab; Kacper  Szpanelewski; Radosław  Kołodziej; Anna Kołodziej; Katarzyna Dziki; Izabella Kula; Wiktor  Adamiec; Damian Danilczuk; Szczepan Półchłopek; Szymon Lulek

doi:10.31435/ijitss.3(51).2026.5752

Authors

Joanna Ciemięga University of Rzeszów, Rzeszów, Poland https://orcid.org/0009-0009-0041-1671
Jakub Klecha Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0003-8909-9181
Emilia Kucab University Clinical Hospital F. Chopin in Rzeszów, Rzeszów, Poland https://orcid.org/0000-0003-4320-6327
Kacper Szpanelewski Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0006-2517-4535
Radosław Kołodziej Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0009-1767-5956
Anna Kołodziej Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0001-0969-5211
Katarzyna Dziki University Clinical Hospital F.Chopin in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0003-9380-1244
Izabella Kula City Hospital of John Paul II in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0002-7379-5062
Wiktor Adamiec City Hospital of John Paul II in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0002-3322-5479
Damian Danilczuk City Hospital of John Paul II in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0005-5755-1115
Szczepan Półchłopek City Hospital of John Paul II in Rzeszów, Rzeszów, Poland https://orcid.org/0000-0003-1188-2830
Szymon Lulek Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0000-3827-2907

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.5752

Keywords:

Diabetes Mellitus, Continuous Glucose Monitoring (CGM), Self-Monitoring of Blood Glucose (SMBG), Mobile Health, Insulin Therapy

Abstract

Diabetes mellitus is a major challenge for global health. It is characterized by rising prevalence, often delayed diagnosis, and significant clinical and economic burden. During the last two decades, Continuous Glucose Monitoring systems have become one of the most important developments in the management of DM. In this short review, we will describe the importance of the research on CGM systems, their advantages over previously available monitoring methods, as well as their limitations that still need to be addressed by manufacturers and physicians managing patients' treatment. We also dedicate a section of this article to newly emerging solutions, including insulin therapy with CGMs as a base and new directions in CGM applications across the medical field.

References

International Diabetes Federation. (2025). IDF diabetes atlas (11th ed.). https://diabetesatlas.org

American Diabetes Association. (2009). Diagnosis and classification of diabetes mellitus. Diabetes Care, 32(Suppl. 1), S62–S67.

Cyganek, K., & Małecki, M. (2010). Zastosowanie ciągłego monitorowania glikemii u chorych na cukrzycę: Przegląd dostępnych systemów. Diabetologia Praktyczna, 11(5). https://ruj.uj.edu.pl/xmlui/handle/item/244950

Towfigh, A., Romanova, M., Weinreb, J. E., et al. (2008). Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: A meta-analysis. American Journal of Managed Care, 14(7), 468–475.

McIntosh, B., Yu, C., Lal, A., et al. (2010). Efficacy of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin: A systematic review and meta-analysis. Open Medicine, 4(2), e102–e113. https://doi.org/10.2478/v10100-010-0008-3

Boland, E., Monsod, T., Delucia, M., Brandt, C. A., Fernando, S., & Tamborlane, W. V. (2001). Limitations of conventional methods of self-monitoring of blood glucose: Lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care, 24(11), 1858–1862. https://doi.org/10.2337/diacare.24.11.1858

Vincze, G., Barner, J. C., & Lopez, D. (2004). Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. The Diabetes Educator, 30(1), 112–125. https://doi.org/10.1177/014572170403000119

Lin, R., Brown, F., James, S., et al. (2021). Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus. Diabetic Medicine, 38, e14528. https://doi.org/10.1111/dme.14528

Babaya, N., Noso, S., Hiromine, Y., et al. (2020). Flash glucose monitoring in type 1 diabetes: A comparison with self-monitoring blood glucose. Journal of Diabetes Investigation, 11(5), 1222–1229. https://doi.org/10.1111/jdi.13229

Chen, C., Zhao, X. L., Li, Z. H., et al. (2017). Current and emerging technology for continuous glucose monitoring. Sensors, 17(1), 182–201.

Battelino, T., et al. (2019). Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care, 42(8), 1593–1603. https://doi.org/10.2337/dci19-0028

Rodbard, D. (2014). Characterizing accuracy and precision of glucose sensors and meters. Journal of Diabetes Science and Technology, 8(5), 980–985. https://doi.org/10.1177/1932296814541810

Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., Davis, G., Kruger, D., Bhargava, A., Young, L., McGill, J. B., Aleppo, G., Nguyen, Q. T., Orozco, I., Biggs, W., . . . MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA, 325(22), 2262–2272. https://doi.org/10.1001/jama.2021.7444

Pickup, J. C., Ford Holloway, M., & Samsi, K. (2015). Real-time continuous glucose monitoring in type 1 diabetes: A qualitative framework analysis of patient narratives. Diabetes Care, 38(4), 544–550. https://doi.org/10.2337/dc14-1855

Bailey, T. S., Liljenquist, D. R., Denham, D. S., et al. (2025). Evaluation of accuracy and safety of the 365-day implantable Eversense continuous glucose monitoring system: The ENHANCE study. Diabetes Technology & Therapeutics, 27(5), 407–411. https://doi.org/10.1089/dia.2024.0592

Messer, L. H., Johnson, R., Driscoll, K. A., & Jones, J. (2017). Best friend or spy: A qualitative meta-synthesis on the impact of continuous glucose monitoring on life with type 1 diabetes. Diabetic Medicine. https://doi.org/10.1111/dme.13568

Al Hayek, A. A., & Al Dawish, M. A. (2020). Assessing diabetes distress and sleep quality in young adults with type 1 diabetes using FreeStyle Libre: A prospective cohort study. Diabetes Therapy, 11(7), 1551–1562. https://doi.org/10.1007/s13300-020-00849-3

Ciechański, M., Witkowska, E., Ostańska, A., Szafran, A., Wiśniewska, K., Piasek, L., Godek, G., Więcław, K., Stańko, K., & Terelak, W. (2023). Pros and cons of continous glucose monitoring. Journal of Medical Science, 93(1), e873. https://doi.org/10.20883/medical.e873

Heinemann, L., & Kamann, S. (2016). Adhesives used for diabetes medical devices: A neglected risk with serious consequences? Journal of Diabetes Science and Technology, 10(6), 1211–1215. https://doi.org/10.1177/1932296816662949

Akturk, H. K., & Bindal, A. (2024). Advances in diabetes technology within the digital diabetes ecosystem. Journal of Managed Care & Specialty Pharmacy, 30(10-b Suppl), S7–S12. https://doi.org/10.18553/jmcp.2024.30.10-b.s7

Shah, R. B., Patel, M., Maahs, D. M., & Shah, V. N. (2016). Insulin delivery methods: Past, present and future. International Journal of Pharmaceutical Investigation, 6(1), 1–9. https://doi.org/10.4103/2230-973X.176456

Cranston, I., Jamdade, V., Liao, B., & Newson, R. S. (2023). Clinical, economic, and patient-reported benefits of connected insulin pen systems: A systematic literature review. Advances in Therapy, 40, 2015–2037. https://doi.org/10.1007/s12325-023-02473-5

Zheng, Y., Campbell, R., Rice, B., Melkus, G. D., Sun, M., Zweig, S., Jia, W., et al. (2023). Dietary self-management using mobile health technology for adults with type 2 diabetes: A scoping review. Journal of Diabetes Science and Technology, 17(5), 1212–1225. https://doi.org/10.1177/19322968231174038

Gottfried, S., Pontiggia, L., Newberg, A., Laynor, G., & Monti, D. (2022). Continuous glucose monitoring metrics for earlier identification of pre-diabetes: Protocol for a systematic review and meta-analysis. BMJ Open, 12, e061756. https://doi.org/10.1136/bmjopen-2022-061756

Hermanns, N., Ehrmann, D., Kulzer, B., Klinker, L., Haak, T., & Schmitt, A. (2025). Somatic and mental symptoms associated with dysglycaemia, diabetes-related complications and mental conditions in people with diabetes: Assessments in daily life using continuous glucose monitoring and ecological momentary assessment. Diabetes, Obesity and Metabolism, 27(1), 61–70. https://doi.org/10.1111/dom.15983

Ji, S., Dong, C., Chen, R., Shen, C., Xiao, J., Gu, Y., et al. (2022). Effects of variability in glycemic indices on longevity in Chinese centenarians. Frontiers in Nutrition, 9, 955101. https://doi.org/10.3389/fnut.2022.955101

American Diabetes Association. (2019). Glycemic targets: Standards of medical care in diabetes—2019. Diabetes Care, 42(Suppl. 1), S61–S70. https://doi.org/10.2337/dc19-S006

Rodbard, D. (2017). Continuous glucose monitoring: A review of recent studies demonstrating improved glycemic outcomes. Diabetes Technology & Therapeutics, 19(S3), S25–S37. https://doi.org/10.1089/dia.2017.0035

Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., Toschi, E., & Wolpert, H. (2017). Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA, 317(4), 371–378. https://doi.org/10.1001/jama.2016.19975